The estimated Net Worth of Ted William Karkus is at least $13 Million dollars as of 1 February 2023. Mr Karkus owns over 500,000 units of ProPhase Labs Inc stock worth over $10,400,635 and over the last 14 years he sold PRPH stock worth over $2,128,900. In addition, he makes $445,000 as Chairman & CEO at ProPhase Labs Inc.
Sign up
Mr Karkus PRPH stock SEC Form 4 insiders trading
Mr has made over 19 trades of the ProPhase Labs Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 500,000 units of PRPH stock worth $300,000 on 1 February 2023.
The largest trade he's ever made was exercising 600,000 units of ProPhase Labs Inc stock on 13 January 2023 worth over $360,000. On average, Mr trades about 191,521 units every 128 days since 2010. As of 1 February 2023 he still owns at least 3,852,087 units of ProPhase Labs Inc stock.
You can see the complete history of Mr Karkus stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Ted William Karkus biography
Ted William Karkus is the Chairman & CEO at ProPhase Labs Inc.
What is the salary of Mr Karkus?
As the Chairman & CEO of ProPhase Labs Inc, the total compensation of Mr Karkus at ProPhase Labs Inc is $445,000. There are no executives at ProPhase Labs Inc getting paid more.
How old is Mr Karkus?
Mr Karkus is 62, he's been the Chairman & CEO of ProPhase Labs Inc since . There are 1 older and 4 younger executives at ProPhase Labs Inc. The oldest executive at ProPhase Labs Inc is Louis Gleckel, 64, who is the Independent Director.
What's Mr Karkus's mailing address?
Ted's mailing address filed with the SEC is 711 STEWART AVE,, SUITE 200, GARDEN CITY,, NY, 11530.
Insiders trading at ProPhase Labs Inc
Over the last 14 years, insiders at ProPhase Labs Inc have traded over $6,868,501 worth of ProPhase Labs Inc stock and bought 2,996,691 units worth $4,189,802 . The most active insiders traders include Braden Michael Leonard, Ted William Karkus, and James T Mccubbin. On average, ProPhase Labs Inc executives and independent directors trade stock every 98 days with the average trade being worth of $586,896. The most recent stock trade was executed by Ted William Karkus on 1 February 2023, trading 500,000 units of PRPH stock currently worth $300,000.
What does ProPhase Labs Inc do?
prophase labs is a diversified natural health medical science company. for more information visit us at www.prophaselabs.com.
What does ProPhase Labs Inc's logo look like?
Complete history of Mr Karkus stock trades at ProPhase Labs Inc
ProPhase Labs Inc executives and stock owners
ProPhase Labs Inc executives and other stock owners filed with the SEC include:
-
Ted William Karkus,
Chairman & CEO -
Monica Brady,
Chief Financial Officer -
Ted Karkus,
Chairman of the Board, Chief Executive Officer -
Monica Brady,
Chief Financial Officer -
Warren Hirsch,
Independent Director -
Louis Gleckel,
Independent Director -
Jason Barr,
Independent Director -
Sergio Miralles,
Exec. VP & Chief Information Officer of ProPhase Diagnostics -
Sam A. Beeler,
Chief Strategy Officer of Precision Medicine -
Jason Karkus,
Exec. VP & Co-COO -
Alice Lioi,
Exec. VP & Co-COO -
Mark S Leventhal,
Director -
Mark Shawn Frank,
Director -
James T Mccubbin,
Director -
Mark A. Burnett,
Director -
Braden Michael Leonard,
10% owner -
Guy J Quigley,
10% owner -
Robert V Jr Cuddihy,
Chief Operating Officer -
John De Shazo,
Director -
Jed Latkin,
Director -
Robert A. Jr. Morse,
CHIEF FINANCIAL OFFICER